BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17928356)

  • 1. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
    Kaletsky RL; Simmons G; Bates P
    J Virol; 2007 Dec; 81(24):13378-84. PubMed ID: 17928356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
    Chandran K; Sullivan NJ; Felbor U; Whelan SP; Cunningham JM
    Science; 2005 Jun; 308(5728):1643-5. PubMed ID: 15831716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.
    Schornberg K; Matsuyama S; Kabsch K; Delos S; Bouton A; White J
    J Virol; 2006 Apr; 80(8):4174-8. PubMed ID: 16571833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.
    Fels JM; Bortz RH; Alkutkar T; Mittler E; Jangra RK; Spence JS; Chandran K
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
    Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
    PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
    Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ
    J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B & L are not required for ebola virus replication.
    Marzi A; Reinheckel T; Feldmann H
    PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.
    González-Hernández M; Müller A; Hoenen T; Hoffmann M; Pöhlmann S
    Virology; 2019 Jun; 532():22-29. PubMed ID: 30999160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
    Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
    J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.
    Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Ebola virus infects cells.
    Kawaoka Y
    N Engl J Med; 2005 Jun; 352(25):2645-6. PubMed ID: 15972874
    [No Abstract]   [Full Text] [Related]  

  • 12. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
    Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
    J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
    Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
    Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
    mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution.
    Beniac DR; Booth TF
    Sci Rep; 2017 Apr; 7():46374. PubMed ID: 28397863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of the Ebola virus glycoprotein by the proprotein convertase furin.
    Volchkov VE; Feldmann H; Volchkova VA; Klenk HD
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5762-7. PubMed ID: 9576958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.